PRCH vs CURI โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
CURI Captures Institutional Edge (2โ2 Pillars ยท 6โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to CuriosityStream Inc. Class A Common Stock (CURI) driven by superior Valuation, Growth & Margin while PRCH counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, PRCH trades at 62.6x Forward P/E with 8.0% operating margin (+13.0% YoY revenue) versus CURI at 8.7x Forward P/E and 10.1% operating margin (+12.9% YoY). In options structure, PRCH sits in BREAKOUT (13th %ile IV; Dealer Gamma Walls on Pro) against CURI sits in CONSOLIDATION (55th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | PRCH Revenue | CURI Revenue | PRCH Op. Margin | CURI Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2019 | $80M | $20M | -113.6% | -247.4% | PRCH |
| FY2020 | $70M | $40M | -58.4% | -97.9% | PRCH |
| FY2021 | $190M | $70M | -43.3% | -73.6% | PRCH |
| FY2022 | $280M | $80M | -64.2% | -70.8% | PRCH |
| FY2023 | $290M | $60M | -66.2% | -78.2% | PRCH |
| FY2024 | $310M | $50M | -20.6% | -26.1% | PRCH |
| FY2025 | $420M | $70M | 8.7% | -10.2% | PRCH |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | PRCH | CURI | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $2.4B | $185.7M | Larger Scale | PRCH |
| Trailing P/E Ratio Valuation | N/M | 20.9x | Lower Multiple | CURI |
| Forward P/E Ratio Valuation | 62.6x | 8.7x | Lower Multiple | CURI |
| Revenue Growth (YoY) Growth | +13.0% | +12.9% | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | 8.0% | 10.1% | Higher Margin | CURI |
| Net Profit Margin Profitability | 1.8% | 11.0% | Higher Margin | CURI |
| Return on Equity (ROE) Capital Efficiency | 5.6% | 19.3% | Higher ROE | CURI |
| 52-Week Range Position Momentum | 91% ($6โ$22) | 32% ($2โ$5) | Stronger Trend | PRCH |
| Beta / 30D Volatility Risk Regime | 1.59ฮฒ ยท 114% Vol | 1.29ฮฒ ยท 94% Vol | Lower Realized Risk | CURI |
| Unified Institutional Score Composite Signal | 47.3 / 100 (HOLD) | 36.5 / 100 (SELL) | Higher Composite | PRCH |